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              DNA double-strand breaks (DSBs) represent 
serious threats to cell survival, and inappropriate 
response to this threat may lead to genome in-
stability and development of cancer. DSBs can 
be caused by exogenous agents such as ionizing 
radiation or certain chemicals, but can also arise 
during normal endogenous processes, including 
DNA replication and meiosis. There are two 
major pathways for repair of DSBs: homolo-
gous recombination (HR) and nonhomologous 
end-joining (NHEJ). The former is dependent 
on sequence homology, is error free, and is 
most active in the late S/G2 phase of the cell 
cycle. The latter utilizes little, or no, sequence 
homology, is often imprecise, functions through-
out the cell cycle, and is considered to be the 
principle mechanism used in vertebrate cells 
(  1, 2  ). The classical NHEJ machinery requires a 
set of proteins, including Ku70, Ku80, DNA-
PKcs, DNA ligase IV, XRCC4, Artemis and 
the recently identifi  ed XLF (Cernunnos) (  3, 4  ). 
Alternative, or backup, NHEJ pathway(s), usu-
ally involving terminal microhomologies, have 
also been described (  1, 2  ). 
  DSBs are also intermediates for V(D)J re-
combination and class switch recombination 
(CSR), two physiological processes that are im-
portant for the generation of functional antigen 
receptors. During early B and T lymphocyte 
development, V(D)J recombination takes place 
to assemble the variable (V) region of the T cell 
receptor and Ig genes, giving rise to a large rep-
ertoire of specifi  cities (  5  ). In mature B cells, 
CSR allows previously rearranged Ig heavy-
chain V domains to be expressed in association 
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  DNA double-strand breaks (DSBs) introduced in the switch (S) regions are intermediates 
during immunoglobulin class switch recombination (CSR). These breaks are subsequently 
recognized, processed, and joined, leading to recombination of the two S regions. Nonho-
mologous end-joining (NHEJ) is believed to be the principle mechanism involved in DSB 
repair during CSR. One important component in NHEJ, Artemis, has however been consid-
ered to be dispensable for effi  cient CSR. In this study, we have characterized the S recom-
binational junctions from Artemis-defi  cient human B cells. S      –  S     junctions could be 
amplifi  ed from all patients tested and were characterized by a complete lack of   “  direct  ”   
end-joining and a remarkable shift in the use of an alternative, microhomology-based end-
joining pathway. S      –  S     junctions could only be amplifi  ed from one patient who carries 
  “  hypomorphic  ”   mutations. Although these S      –  S     junctions appear to be normal, a signifi  -
cant increase of an unusual type of sequential switching from immunoglobulin (Ig)M, 
through one IgG subclass, to a different IgG subclass was observed, and the S      –  S     junc-
tions showed long microhomologies. Thus, when the function of Artemis is impaired, vary-
ing modes of CSR junction resolution may be used for different S regions. Our fi  ndings 
strongly link Artemis to the predominant NHEJ pathway during CSR. 
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T       B       NK  +   SCID, and patient AKE was diagnosed with pro-
gressive CID. A1 and A7 carry homozygous gross deletions 
in the   Artemis   gene, whereas A8 has a homozygous deletion 
of fi  ve nucleotides resulting in a frame shift and premature 
stop codon (  Table I  ). AKE is a compound heterozygote with 
a 3-bp deletion on one allele and a missense mutation on the 
other allele, resulting in Artemis proteins with an L70 dele-
tion or a G126D substitution (  22, 25  ). Both mutations have 
an impact on Artemis function, and the level of Artemis pro-
tein is greatly reduced in the patient  ’  s cells (  22  ). The muta-
tions from this patient were, however, less devastating, or 
  “  hypomorphic,  ”   as both the clinical and cellular phenotypes 
were less severe compared with the other three patients. 
  To determine whether CSR was aff  ected by a lack of 
functional Artemis, individual S      –  S     junctions were ampli-
fi  ed using our previously developed nested-PCR assay (  26  ). 
The number of S      –  S     fragments was determined from 10 
PCR reactions run in parallel using DNA from each individ-
ual. As shown in   Fig. 1 A  , the number and intensity of ampli-
fi  ed bands were lower in the Artemis patients.   Patient AKE 
had a normal number of B cells but the number of clones that 
had switched to IgA was 3  –  9 fold reduced, as estimated by 
serial titration of control DNA templates. Patients A1, A7, 
and A8 had extremely low numbers of B cells (undetectable 
by routine FACS analysis), thus it is diffi   cult to estimate the 
proportion of B cells that have switched to IgA. It is impor-
tant to note that S      –  S     fragments could still be amplifi  ed 
from DNA samples from all three patients, including patients 
A1 and A7, who carry large genomic deletions and with no 
functional protein (  Fig. 1 A   and not depicted). The weak 
bands amplifi  ed from the patients, indeed, represent bona 
fi  de CSR junctions (see the following paragraph). Residual 
IgA switching thus appears to occur even in the complete 
absence of functional Artemis protein. 
  Altered pattern of S      –  S     recombination junctions 
  The amplifi  ed S      –  S     fragments were subsequently sequenced 
and compared with germline S     and S     sequences to defi  ne the 
switch junctions. Altogether, 54 unique S      –  S     sequences 
from Artemis-defi  cient patients were obtained (Fig. S1, available 
at http://www.jem.org/cgi/content/full/jem.20081915/DC1) 
and compared with 141 S      –  S     fragments from age-matched 
controls (Fig. S2). One sequence from each patient and 4 
junctions from controls are shown in   Fig. 1 B  . 
  Switching to     1 occurred more often than to     2 both in 
patients and controls (65 and 77%, respectively). Sequential 
switching through S    , involving two nonhomologous re-
combination processes (S     to S     and S     to S    ), was not ob-
served in the patients, although it represents     3% (4 out of 
141) of IgA switching events in the age-matched controls 
(7% in our previously described adult controls [  11, 26  ]). 
  There was a strikingly high degree of overlap between the S μ   
and S     sequences in recombination junctions derived from the 
Artemis patients (8.0   ±   6.2 vs. 3.9   ±   5.1 nucleotides in controls; 
  Fig. 1, B and C,   and   Table II  ; Student  ’  s   t   test, P   <   0.0001).   
This was caused by a signifi  cantly decreased proportion of 
with a diff  erent constant (C) region, leading to production of 
diff  erent isotypes (IgG, IgA, or IgE) with improved biological 
eff  ector functions (  6, 7  ). The seven known components of 
the classical NHEJ are all essential for the V(D)J recombina-
tion process (  4, 5  ) and the   “  alternative NHEJ  ”   pathway seems 
to be suppressed by the Rag proteins and operative (still inef-
fi  ciently) only when the classical NHEJ fails (  8, 9  ). In contrast 
to V(D)J recombination, the alternative, microhomology-
based end-joining pathway is functional to some extent dur-
ing CSR in normal cells, and is more eff  ective when the 
classical NHEJ fails (  10  –  12  ). 
  Five components of the classical NHEJ (Ku70, Ku80, 
DNA-PKcs, DNA ligase IV, and XRCC4) have been shown 
to be important for CSR (  11  –  16  ). XLF defi  ciency has been 
described in a few patients with growth retardation, micro-
cephaly, and immunodefi  ciency (  4  ). The serum levels of IgA 
and IgG in these patients are low or absent, accompanied by 
normal or high levels of IgM, suggesting an involvement of 
XLF in CSR (  4  ). In support of this notion, a recent study has 
shown that XLF-defi  cient mouse B cells are moderately de-
fective in CSR (  17  ). Artemis has only been considered to 
have a restricted role in V(D)J recombination (hairpin open-
ing activity) and to be altogether dispensable for CSR (  18  ). 
  In humans, mutations in   Artemis   (  DCLRE1c  ) result in 
T       B       NK  +   severe combined immunodefi  ciency (SCID) as-
sociated with increased radiosensitivity, a disorder that is 
characterized by a severe defect in V(D)J recombination lead-
ing to an early arrest of both B and T cell maturation (  19  ). 
Hypomorphic mutations in the gene have also been described 
and are associated either with Omenn  ’  s syndrome, which is a 
  “  leaky  ”   form of T       B       NK  +   SCID (  20  ), or CID (  21, 22  ). The 
latter group of patients (with CID) does have polyclonal 
T and B lymphocyte populations, albeit in reduced numbers, 
but with extremely low levels, or absence of serum IgG and 
IgA (  21, 22  ). It is possible that a lower effi   ciency of CSR, in 
addition to the defective V(D)J recombination, contributes 
to the immunodefi  ciency observed in these patients. Further-
more, Artemis is absolutely required for repairing     10% of 
the DSBs induced by      irradiation, representing breaks re-
joined with a slow kinetics in mammalian cells (  23  ). It is 
tempting to speculate that Artemis may also have a role in 
CSR, i.e., in the processing of a subset of DSBs with more 
complex ends where the repair requires a longer time. In 
support of this hypothesis, Franco et al. have recently shown 
that Artemis-defi  cient B cells, activated to undergo CSR, 
showed an increased number of chromosomal breaks at the 
Ig locus (  24  ). To further investigate the role of Artemis in 
end-joining during CSR, we therefore performed a detailed 
analysis of the switch (S) recombination junctions in B cells 
from Artemis-defi  cient patients. 
    RESULTS   
  Switching to IgA in Artemis-defi  cient patients 
  Genomic DNA was prepared from peripheral blood from 4 
Artemis-defi   cient patients (  Table I  ) and 14 age-matched 
controls.   Patients A1, A7, and A8 were diagnosed with JEM VOL. 205, December 22, 2008 
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P   <   0.001;   Table III  ). Similarly, most of the 1-bp insertions 
also occurred at A/T sites (80 vs. 15% in controls;       2   test, P   <   
0.001). The reduced rate of mutations or insertions close 
to, or at, the CSR junctions could be a feature coupled to the 
increased requirement for a long microhomology, as in 
ATM- or DNA ligase IV  –  defi  cient patients (  11, 26  ). The 
dominant A/T mutations/insertions around, or at, the S      –
  S     junctions, is, however, a unique feature in Artemis-defi  -
cient patients, as the few mutations observed in ATM- or 
DNA ligase IV  –  defi  cient patients were mainly located at G/C 
sites (83% for both patient groups;   Table III  ). 
  Point mutations can often be observed in the recombined 
S     region, away from (starting 15 bp upstream) the recombi-
nation breakpoints (  28  ). The pattern of these mutations is 
similar to those in the V regions (thus they are referred to as 
somatic hypermutation [SHM]-like), but diff  erent from those 
close to, or at, the recombination breakpoints (  ±  15 bp) (  28  ). 
In Artemis-defi  cient patients, SHM-like mutations were ob-
served at a slightly lower (but not signifi  cantly diff  erent) level 
as compared with those from controls (  Table III  ). However, 
the general pattern of base substitutions was again altered, 
occurring more frequently at A/T sites (58 vs. 30% in con-
trols;       2   test, P   <   0.001) and less often being associated with 
the SHM hotspot motifs (RGYW/WRCY; R, A or G; Y, C 
or T; W, A or T;   Table III  ). 
  As patients A1, A7, and A8 had barely detectable periph-
eral B cells, it is possible that the S      –  S     junctions amplifi  ed 
for these patients originate from a very minor and potentially 
skewed B cell pool. However, as a vast majority of the S      –  S     
junctions amplifi  ed from patients A1, A7, and A8 (28 of 29 
junctions) had a unique sequence, the B cell pool in these 
patients is still considerable. Furthermore, the pattern of S      –
  S     junctions in these three patients is very similar to patient 
AKE, who had a normal number of B cells. Long micro-
homologies and a complete lack of direct end-joining are 
characteristic for all patients. The frequency and pattern of 
mutations at the S      –  S     junctions, or in the recombined S     
regions, is also very similar (unpublished data). Thus, the al-
tered S      –  S     junctions in patients A1, A7, and A8 is unlikely 
to be caused by a restricted B cell pool. 
  Our previously described 154 control S      –  S     junctions 
were amplifi  ed from PBL from 17 healthy adults (  11, 26  ), 
whereas the 137 control S      –  S     junctions described here 
were obtained from 14 healthy children (1  –  6 yr old). It is 
S      –  S     junctions with no microhomology (11 vs. 42% in 
controls;       2  test, P   <   0.001) and a signifi  cantly increased pro-
portion of junctions exhibiting a long microhomology of   ≥  10 
bp (39 vs. 16%;       2  test, P   <   0.0001;   Fig. 1 C   and   Table II  ). 
When one mismatch was allowed at either side of the recom-
bination breakpoint, a majority of the junctions were fl  anked 
by   ≥  10/11 bp of imperfect repeats (43 + 41 = 84 vs. 33% 
in controls;       2  test, P   <   0.001; Table S1, available at http://
www.jem.org/cgi/content/full/jem.20081915/DC1). This 
dramatic shift in the use of long microhomologies or imper-
fect repeats in the S      –  S     junctions has previously only been 
observed in patients with DNA ligase IV defi  ciency (  Table II   
and Table S1) (  11  ), and, to a lesser degree, in patients with a 
subtype of the Hyper IgM syndrome (  27  ) and ataxia-telangi-
ectasia (A-T, ATM defi  cient) (  26  ). 
  The six S      –  S     junctions (11% of total junctions) from 
Artemis-defi  cient patients that did not exhibit a perfect se-
quence homology (0 bp microhomology) can all be defi  ned 
as having a 1-bp insertion (  Table II  ). Typically, these junc-
tions were also fl  anked by long imperfect repeats (A7-1 in 
  Fig. 1 B  ). In controls,     60% of the S      –  S     junctions with 0-bp 
microhomology could be classifi  ed as having a 1-bp inser-
tion (25% of total junctions), and these junctions were not 
necessarily associated with long imperfect repeats (C29-271 
in   Fig. 1 B  ). The remaining 40% of control junctions with 
0 bp microhomology could be defi  ned as   “  direct  ”   end-joining, 
i.e., no microhomology and no insertions (exemplifi  ed by 
C5-230 and C29-261 in   Fig. 1 B  ; 18% of total junctions,   Ta-
ble II  ). When a stricter rule was applied, i.e., no microhomol-
ogy, no insertions, and no mutations close to the junctions, 
there were still 10% of the total control junctions (14 out of 
137, exemplifi  ed by C5-230) that could be classifi  ed as   “  per-
fect  ”   or   “  precise direct  ”   end-joining. Thus, in the absence of 
Artemis, recombination of the S     and S     regions is heavily 
dependent on the alternative end-joining pathway(s) that re-
quire long microhomologies, and the ability of cells to join 
these two S regions by direct end-joining mechanism(s) ap-
pears to be totally lost. 
  The frequency of mutations around the S      –  S     junctions 
(  ±   15 bp) was signifi  cantly reduced in Artemis-defi  cient pa-
tients (5.6 vs. 12.4 mutations/1,000 bp;       2   test, P   <   0.05; 
  Table III  ).   Furthermore, the general pattern of base substitu-
tions was signifi  cantly altered as a majority of the mutations 
occurred at A/T residues (89 vs. 25% in controls;       2   test, 
    Table I  .  Serum immunoglobulin levels in Artemis patients 
Patient ID Diagnosis Age at sampling B cell count  Serum Ig levels (g/liter)   Artemis   mutations References
  % IgM IgG IgA
A1 T       B       NK  +   SCID 5 mo   <  0.01 NA    a    NA NA deletion of exon 10, 11, 12 (ho) (  42  )
A7 T       B       NK  +   SCID 7 mo 0   <  0.04 3.38    b     <  0.07 deletion of exon 1, 2, 3 (ho) (  43  )
A8 T       B       NK  +   SCID 6 mo   <  0.01 0.13 5.7    b   0.1 1391-1395delGAATC  (ho) (  39  )
AKE CID 4 yr 33    c   2.3   <  2.0   <  0.4 207-209delGTT (he)/377G  >  A (he) (  22  ,   25  )
  a  NA, not available.
  b  IgG could be of maternal origin.
  c  The absolute B cell count: 353 cells/  μ  l.3034 ARTEMIS DEFICIENCY AND CSR   | Du et al. 
  Figure 1.       Characterization of S      –  S     junctions in Artemis-defi  cient patients.   (A) PCR amplifi  cation of S    – S    fragments. Three experiments were 
performed and a representative example is shown in the fi  gure. The number of S    – S    fragments was determined from 10 PCR reactions run in parallel 
(lane 1  –  10) using DNA from each individual. M, molecular weight marker (1-kb DNA ladder from Invitrogen). (B) Sequence of S    – S    junctions. The S    
and S     sequences are aligned above and below the recombination junctional sequences. Microhomology is indicated by a box (solid line). Imperfect re-
peat was determined by identifying the longest overlap region at the switch junction by allowing one mismatch on either side of the breakpoints (the 
extra nucleotide identifi  ed beyond the perfectly matched sequence identity is boxed by a dotted line). OL, overlap. The S     and  S    breakpoints for each 
switch fragment are indicated by      and     , respectively, and their positions in the germ line sequences are indicated on top of or below the arrowheads. 
(C) Pie charts demonstrate the microhomology usage at S    –  S     junctions in patients and controls. The proportion of switch junctions with a given size of 
perfectly matched short homology is indicated by the size of the slices.     JEM VOL. 205, December 22, 2008 
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showing a long microhomology (  ≥  10 bp) was signifi  cantly 
increased (16 vs. 3% in the adult controls;       2  test, P   <   0.001; 
  Table II  ). The proportion of junctions with 4  –  6 or 7  –  9 bp of 
microhomology is, however, similar in the two groups (  Ta-
ble II  ). Furthermore, the proportion of junctions with a 1-bp 
worth noting that there are some diff  erences between the 
two groups. Thus, the proportion of S      –  S     junctions with a 
short microhomology (1  –  3 bp) was signifi  cantly decreased in 
the younger controls (18 vs. 36% in adult controls;       2  test, 
P   <   0.001;   Table II  ), whereas the proportion of junctions 
    Table II  .  Characterization of S    –  S     and S    –  S     junctions  a   ,   b   
Perfectly matched short homology Total no. of 
  S fragments
0 bp 1-3 bp 4  –  6 bp 7  –  9 bp   ≥  10 bp
1-bp insertions No insertions 
  S    – S    
Artemis      /       6 (11%)*   0 (0%)**  10 (19%) 8 (15%) 9 (17%)   21 (39%)*** 54
Controls (1-6 y) 34 (25%) 24 (18%) 25 (18%) 21 (15%) 11 (8%) 22 (16%) 137
Ligase IV      /       1 (3%)**   0 (0%)***  7 (23%) 4 (13%) 4 (13%)   14 (47%)*** 30
ATM      /       1 (2%)***   1 (2%)**  15 (34%) 9 (20%) 5 (11%)   13 (30%)*** 44
Controls (adults) 39 (25%) 28 (18%) 56 (36%) 15 (10%) 11 (7%) 5 (3%) 154
  S    – S    
Artemis      /         c    4 (17%) 5 (21%) 14 (58%) 1 (4%) 0 (0%) 0 (0%) 24
Controls (1-6 y) 9 (16%) 13 (22%) 26 (45%) 10 (17%) 0 (0%) 0 (0%) 58
Ligase IV      /       11 (32%)*  4 (12%) 15 (44%) 4 (12%) 0 (0%) 0 (0%) 34
ATM      /     3 (8%) 3 (8%) 23 (61%)   7 (18%)*  2 (5%) 0 (0%) 38
Controls (adults) 7 (12%) 12 (20%) 37 (63%) 3 (5%) 0 (0%) 0 (0%) 59
  a  The switch junctions from Artemis-defi  cient patients were compared with those from age matched controls (1-6 yr of age), whereas the switch junctions from DNA ligase 
IV –   or  ATM-defi  cient patients were compared with adult controls. Statistical analysis was performed using     2  test. Statistically signifi  cant differences are shown in bold. 
* P   <   0.05; ** P   <   0.01; *** P   <   0.001.
  b  The data from DNA ligase IV  –   and ATM-defi  cient patients and the adult controls have previously been partially described (  11, 26, 30  ).
  c The  S   – S    junctions were obtained from patient AKE.
    Table III  .      Mutations in recombined S    –  S     fragments  a   
No. of mutations 
AT versus GC mutations 
  %
Transitions 
  %
In RGYW/ 
  WRCY motifs %
Total no. 
  of mutations
No. of bp 
  sequenced
Frequency 
  (per 1,000 bp)
Close to the junction (  ±  15 bp)
Artemis      /       8 versus 1 (89 vs. 11%)***  5 (56%) 5 (56%) 9 1,620   5.6* 
Controls (1-6 y) 13 versus 38 (25 vs. 75%) 27 (53%) 28 (55%) 51 4,110 12.4
Ligase IV      /     1 versus 5 (17 vs. 83%) 2 (33%) 5 (83%) 6 900 6.7
ATM      /     1 versus 5 (17 vs. 83%) 1 (17%) 4 (67%) 6 1,320   4.5** 
Controls (adults) 11 versus 56 (16 vs. 84%) 30 (45%) 53 (79%) 67 4,590 14.6
Within S     (  >  15 bp upstream of the 
junction)
Artemis      /       38 versus 28 (58 vs. 42%)*** 43  (65%)   37 (56%)* 66 15,508 4.3
Controls (1-6 yr) 42 versus 59 (30 vs. 70%) 95 (67%) 101 (72%) 141 26,569 5.3
Ligase IV      /     10 versus 8 (56 vs. 44%) 14 (78%) 13 (72%) 18 9,749   1.8*** 
ATM      /       20 versus 16 (56 vs. 44%)*   31 (86%)** 24  (67%) 36 1,1993   3.0** 
Controls (adults) 62 versus 105 (37 vs. 63%) 99 (59%) 117 (70%) 167 31,502 5.3
  a  Statistical analysis was performed using     2  test. Statistically signifi  cant differences are shown in bold. * P   <   0.05; ** P   <   0.01; *** P   <   0.001.3036 ARTEMIS DEFICIENCY AND CSR   | Du et al. 
with G/C mutations being dominant). Thus, the general pat-
tern of S      –  S     junctions from this Artemis-defi  cient patient 
seems to be indistinguishable from controls. 
  It is worth noting, however, that in the Artemis-defi  -
cient patient, S      x    –  S      y   junctions resulting from recombina-
tion of two diff  erent S     regions, showed a strong preference 
for long microhomologies and imperfect repeats (  Fig. 2 B   
and Fig. S5, available at http://www.jem.org/cgi/content/
full/jem.20081915/DC1). All the junctions from the patient 
displayed microhomology, from 3 to 20 bp, with an average 
length of 12.0   ±   7.9 bp, whereas the only S      x    –  S      y   junction 
from controls had a 1-bp insertion. When one mismatch was 
allowed on either side of the junctions, the average length of 
imperfect repeats increased to 23.6 bp, which is even longer 
than that observed at the S      –  S     junctions from the patients 
(14.8 bp). Thus, when the function of Artemis is impaired, 
switching to IgG is more aff  ected than switching to IgA, as 
the microhomology-based, alternative end-joining pathway 
cannot effi   ciently be used as a backup to recombine the S     
and S     regions. This could be caused by the much lower de-
gree of homology between S     and S     as compared with the 
S     and S     regions, where the likelihood of obtaining a 
7-, 10-, or 15-bp microhomology between S      –  S     regions is 
8-, 270-, and   >  1,000-fold lower, respectively, than in the 
S      –  S     regions (  6  ). The diff  erent S     regions, however, share a 
very high degree of homology (  6, 31  ), and once the Artemis-
defi  cient cells have switched to IgG3 or IgG1, the alternative 
pathway can be used to drive a switch to a downstream IgG 
subclass, for instance IgG2, through a recombination of the 
two S     regions. In control cells, however, when the NHEJ 
functions normally, this pathway is almost never used. 
    DISCUSSION   
  Artemis was fi  rst identifi  ed as a nuclease that is specifi  cally re-
quired for cleavage of hairpin intermediates generated during 
V(D)J recombination (  19, 32  ). It has subsequently been 
shown to have a broader role in NHEJ, where it is required 
for repair of     10  –  20% of DSBs induced by      irradiation or 
     particles (  23  ). By analyzing the recombination junctions 
from Artemis-defi  cient patients, we now provide direct evi-
dence that Artemis is also required for CSR, another gene 
rearrangement process that relies on NHEJ. 
  In Artemis-defi   cient patients, the S      –  S     junctions are 
characterized by a strong dependence of long microhomolo-
gies and a complete lack of direct end-joining, which consti-
tutes     18% of the normal S      –  S     recombination events. These 
features are also noted in the S      –  S     junctions derived from 
DNA ligase IV  –   or ATM-defi  cient patients (  Table II  ). This is 
diff   erent from the situation during V(D)J recombination, 
where the hairpin opening activity of Artemis is independent 
of ATM. It is, however, reminiscent of the situation after     -ir-
radiation, where Artemis, ATM, and DNA ligase IV function 
in a common repair pathway, responsible for processing of a 
subset of DSBs (  23  ). Although the structure and chemistry of 
the DNA ends involved in this subset of DSBs are unknown, 
it has been proposed that these ends might be   “  damaged  ”   or 
insertion (25 vs. 25%), which is caused by direct end-joining 
(18 vs. 18%) or precise direct end-joining (10 vs. 10%), was 
identical between the two sets of controls. Moreover, the 
frequency and pattern of mutations around the junctions and 
upstream of the junctions in the young controls are similar to 
those previously described (  Table III  ). Thus, most of the fea-
tures of S      –  S     junctions are conserved among controls, re-
gardless of age. There might, however, be some age-related 
variations in the use of microhomology-dependent end-join-
ing pathways, and appropriate age-matched controls should 
therefore be included when studying the pattern of CSR 
junctions. 
  Switching to IgG in Artemis-defi  cient patients 
  S      –  S     junctions were subsequently amplifi  ed using a nested-
PCR assay (  11, 29  ). S      –  S    1, S      –  S    2, and S      –  S    3 frag-
ments could be detected in cells from patient AKE using the 
respective S    -specifi  c primers (  Fig. 2 A  ).   No S      –  S     frag-
ments could however, be amplifi  ed from patients A1, A7, 
and A8 (  Fig. 2 A   and not depicted). The weak bands ob-
served in all lanes in patients A7 and A8 represent nonspecifi  c 
amplifi  cation (  Fig. 2 A  ). Switching to IgG could thus only be 
detected in cells from patient AKE, who carries hypomorphic 
mutations in   Artemis  . 
  Increased frequency of S      –  S     sequential switching 
in patient AKE 
  The S      –  S     fragments from patient AKE and age-matched 
controls were subsequently cloned and sequenced. Alto-
gether, 24 unique S      –  S     fragments from the patient were 
characterized (Fig. S3, available at http://www.jem.org/cgi/
content/full/jem.20081915/DC1) and compared with 58 
S      –  S     fragments from age matched controls (Fig. S4). Most 
of the S      –  S     fragments from the Artemis-defi  cient patient 
resulted from direct switching from IgM to various IgG sub-
classes. However, a substantial proportion of the fragments 
(5 out of 24, or 21%) showed clear evidence of sequential 
switching from IgM, through one IgG subclass (IgG3 or 
IgG1) to a diff  erent IgG subclass (IgG1 or IgG2, exemplifi  ed 
by AKE-1-3 and AKE-2-9 in   Fig. 2 B  ). This is particularly 
true for switching to IgG2, where, in four out of fi  ve S      –  S    2 
fragments, sequential switching through S    1 or S    3 was evi-
dent. This type of sequential switching (S      –  S      x    –  S      y  ) repre-
sents an extremely rare event in controls (1 out of 58, or 2% 
in the current controls;       2  test, P   <   0.01; 0 of 59, or 0% in 
the previously described controls [  30  ];       2  test, P   <   0.001). 
  At the S      –  S     junctions, in contrast to the S      –  S     junc-
tions, there was no signifi  cant diff  erence in the length of mi-
crohomologies between the patient and control groups (1.4 
  ±   1.2 vs. 1.4   ±   1.6 bp in controls). Furthermore, the propor-
tion of junctions with a 1-bp insertion (17 vs. 16%), caused 
by direct end joining (21 vs. 22%) or precise direct end-join-
ing (8 vs. 7%), was almost identical between patient and con-
trols (  Table II   and not depicted). Moreover, the frequency 
and pattern of mutations around the S      –  S     junctions were 
similar between patient and controls (25 vs. 22 bp/1,000 bp, JEM VOL. 205, December 22, 2008 
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joining of the two S regions. However, as Artemis defi  ciency 
does not aff  ect the effi   ciency and fi  delity of the recombina-
tion signal joints (  16  ), but impairs the direct end-joining dur-
ing CSR, it is unlikely that such ligatable blunt ends exist in 
the CSR reaction without prior processing by Artemis. Arte-
mis exhibits an intrinsic 5    - to 3    -exonuclease activity on 
single-stranded DNA and, when associated with and 
phosphorylated by DNA-PKcs, it shows endonuclease activ-
ity on overhangs and hairpins (  32, 34  –  36  ). Cleavage of 5     
more   “  complex  ”   and thus require more time for repair and an 
involvement of the nuclease activity of Artemis (  23  ). 
  Based on the known function of Artemis and the   “  mor-
phology  ”   of the S      –  S     junctions, we can deduce which 
types of DNA ends are involved in the direct end-joining 
process (  Fig. 3  ).   Both blunt and staggered ends have been de-
tected in the S regions (  33  ). Theoretically, like the recombi-
nation signal joint formation during V(D)J recombination, 
two blunt ends can be ligated directly, leading to a precise 
    Figure 2.         Characterization of S      –  S     junctions in Artemis-defi  cient patients.   (A) PCR amplifi  cation of S    – S  1,  S   –  S    2, and S    – S  3  fragments. 
Three experiments were performed and a representative example is shown in the fi  gure. (B) S    – S   – S    sequential switching in AKE, showing the actual 
sequences of the S    – S    and  S   – S    junctions.   3038 ARTEMIS DEFICIENCY AND CSR   | Du et al. 
in   Fig. 3  ) (  37  ). No terminal microhomology is required in 
this type of end-joining, and this could explain the depen-
dence of direct end-joining by Artemis, DNA ligase IV/
XRCC4, and, possibly, XLF (unpublished data). It is also 
possible that processing by Artemis results in two blunt ends 
that can subsequently be directly ligated (possibility 3 in   Fig. 
3 B  ). Artemis may also convert terminally blocked blunt ends 
overhangs by Artemis preferentially results in a blunt confi  gu-
ration, whereas cleavage of 3     overhangs preferentially leaves 
short overhangs (  35  ). It is possible that Artemis can process a 
pair of noncompatible ends to one blunt end and one 3     
overhang end, and Ku, DNA ligase IV/XRCC4, and XLF 
will subsequently promote ligation of such modifi  ed  ends 
while retaining the 3     overhang sequence (possibility 1 and 2 
    Figure 3.         Hypothetical model for Artemis-dependent direct end-joining during CSR.   The  fi  gure shows several possible ways of end processing by 
Artemis that may lead to the precise direct end-joining in junction C5-230 (a control junction presented in   Fig. 1 B  ). (A) Possibility 1 is illustrated using 
the actual sequence of the junction. (B) Schematic models for possibilities 1  –  4. In possibility 1 and 2, Artemis cleavage of the 5     overhang at one end, 
leads to a blunt confi  guration. On the other end, it cleaves the 3     overhang, resulting in a short overhang with a few nucleotides. Solid arrows indicate 
the positions where Artemis acts. Ku, XRCC4/Ligase IV, and XLF promote the ligation of the 3     overhanging hydroxyl group to the 5     phosphate of the 
blunt end, leaving the other strand unjoined. The gap in the unjoined strand will then be fi  lled in by a high fi  delity DNA polymerase using the 3     overhang 
sequence as a template (indicated by a dotted arrow). This strand will then be ligated by DNA ligase IV/XRCC4. In possiblity 3, both ends carry 5     over-
hangs, and processing by Artemis results in the formation of two ligatable blunt ends. In possibility 4, Artemis converts the terminally blocked blunt ends 
(marked by fi  lled circles) to ligatable blunt ends.     JEM VOL. 205, December 22, 2008 
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  Artemis   gene, B cell counts, and immunoglobulin levels of the patients are 
summarized in   Table I  . The institutional review board at the Karolinska In-
stitutet approved the study. 
  Amplifi  cation and analysis of switch recombination junctions.     Ge-
nomic DNA was purifi  ed from peripheral blood cells from patients and 
healthy blood donors. The amplifi  cation of S      –  S     and S      –  S     fragments 
from in vivo switched cells was performed as previously described (  11, 26, 
29, 40, 41  ), except that a modifi  ed version of   Taq   polymerase (Go Taq; Pro-
mega) was used in the PCR reactions. With this modifi  cation, a two- to 
fourfold increase in sensitivity was achieved. The PCR-amplifi  ed switch 
fragments were gel purifi  ed (QIAGEN), cloned, and sequenced by an auto-
mated fl  uorescent sequencer in the MWG Company or in Macrogen. 
  The switch recombination breakpoints were determined by aligning the 
switch fragment sequences with the S     (X54713)/S    1 (L19121)/S    2 
(AF030305) or S    /S    1 (U39737)/S    2 (U39934)/S    3 (U39935)/S    4 
(Y12547-52) sequences. Analysis of microhomology/imperfect repeat usage 
and mutation pattern at the switch junctions was performed as previously de-
scribed (  26, 28  ). 
  Online supplemental material.     The sequence of S      –  S    , S      –  S    , and S      –
  S     junctions from Artemis patients and controls are presented in Figs. S1  –  S5. 
A summary of imperfect repeats at the S      –  S     junctions from Artemis pa-
tients and controls is presented in Table S1.Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20081915/DC1. 
  This work was supported by the Swedish Research Council, the Swedish Cancer 
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